T.M. Jenkins

1.3k total citations
11 papers, 1.0k citations indexed

About

T.M. Jenkins is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, T.M. Jenkins has authored 11 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Infectious Diseases and 5 papers in Virology. Recurrent topics in T.M. Jenkins's work include HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and Biochemical and Molecular Research (3 papers). T.M. Jenkins is often cited by papers focused on HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and Biochemical and Molecular Research (3 papers). T.M. Jenkins collaborates with scholars based in United Kingdom, United States and Germany. T.M. Jenkins's co-authors include Anton Pozniak, Ian James, Mike Youle, Elna van der Ryst, Manos Perros, Mike Westby, Marilyn Lewis, Jeannette M. Whitcomb, Gerd Fätkenheuer and Schlomo Staszewski and has published in prestigious journals such as Nature Medicine, The EMBO Journal and Journal of Virology.

In The Last Decade

T.M. Jenkins

10 papers receiving 1.0k citations

Peers

T.M. Jenkins

VIROL

IMMUN

EPIDE

Caroline Smith‐Burchnell United Kingdom

Malcolm Macartney United Kingdom

Caroline E. Ridgway United Kingdom

Ronna E. Dornsife United States

Alonso Heredia United States

Patrick Dorr United Kingdom

Herwig Koppensteiner Germany

Christina Gavegnano United States

Daisy Sun United States

Hiromi Ogata Japan

Caroline Smith‐Burchnell United Kingdom

T.M. Jenkins

947 ×1.4

VIROL

727 ×1.2

348 ×1.0

337 ×1.9

IMMUN

202 ×1.4

EPIDE

Citations per year, relative to T.M. Jenkins T.M. Jenkins (= 1×) peers Caroline Smith‐Burchnell

Countries citing papers authored by T.M. Jenkins

Since Specialization

Citations

This map shows the geographic impact of T.M. Jenkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.M. Jenkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.M. Jenkins more than expected).

Fields of papers citing papers by T.M. Jenkins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.M. Jenkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.M. Jenkins. The network helps show where T.M. Jenkins may publish in the future.

Co-authorship network of co-authors of T.M. Jenkins

This figure shows the co-authorship network connecting the top 25 collaborators of T.M. Jenkins. A scholar is included among the top collaborators of T.M. Jenkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.M. Jenkins. T.M. Jenkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Terrault, Norah A., Tarek Hassanein, Charles D. Howell, et al.. (2014). Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure. Journal of Hepatology. 61(6). 1253–1259. 61 indexed citations

Fätkenheuer, Gerd, Schlomo Staszewski, Frances Hackman, et al.. (2009). Activity, pharmacokinetics and safety of lersivirine (UK-453,061), a next-generation nonnucleoside reverse transcriptase inhibitor, during 7-day monotherapy in HIV-1-infected patients. AIDS. 23(16). 2115–2122. 34 indexed citations

Davis, John D., Maurice Dickins, I. Gardner, et al.. (2008). Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of in silico physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man. Xenobiotica. 38(6). 620–640. 46 indexed citations

Westby, Mike, Marilyn Lewis, Jeannette M. Whitcomb, et al.. (2006). Emergence of CXCR4-Using Human Immunodeficiency Virus Type 1 (HIV-1) Variants in a Minority of HIV-1-Infected Patients following Treatment with the CCR5 Antagonist Maraviroc Is from a Pretreatment CXCR4-Using Virus Reservoir. Journal of Virology. 80(10). 4909–4920. 250 indexed citations

Fätkenheuer, Gerd, Anton Pozniak, Margaret Johnson, et al.. (2005). Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. Nature Medicine. 11(11). 1170–1172. 386 indexed citations

Jenkins, T.M.. (1997). Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking. The EMBO Journal. 16(22). 6849–6859. 202 indexed citations

Dyda, Fred, Alison B. Hickman, T.M. Jenkins, et al.. (1996). The crystal structure of the catalytic core domain of HIV-1 integrase in a new crystal form. Acta Crystallographica Section A Foundations of Crystallography. 52(a1). C155–C155. 1 indexed citations

Jenkins, T.M. & P.D.J. Weitzman. (1988). Physiological roles of animal succinate thiokinases Specific association of the guanine nucleotide‐linked enzyme with haem biosynthesis. FEBS Letters. 230(1-2). 6–8. 11 indexed citations

Jenkins, T.M. & P.D.J. Weitzman. (1986). Distinct physiological roles of animal succinate thiokinases Association of guanine nucleotide‐linked succinate thiokinase with ketone body utilization. FEBS Letters. 205(2). 215–218. 24 indexed citations

10.

Weitzman, P.D.J., et al.. (1986). Occurrence of two distinct succinate thiokinases in animal tissues. FEBS Letters. 199(1). 57–60. 18 indexed citations

11.

Jenkins, T.M.. (1968). The first Bushman haemoglobin variant: haemoglobin D beta Bushman alpha-2-beta-2-16 glycine-arginine.. PubMed. 33(1). 13–9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact